AM281
CAS No. 202463-68-1
AM281( AM281 | AM 281 | AM-281 )
Catalog No. M17418 CAS No. 202463-68-1
AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 164 | In Stock |
|
| 10MG | 259 | In Stock |
|
| 25MG | 524 | In Stock |
|
| 50MG | 750 | In Stock |
|
| 100MG | 1035 | In Stock |
|
| 500MG | 2061 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAM281
-
NoteResearch use only, not for human use.
-
Brief DescriptionAM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats.
-
DescriptionAM281 is a synthetic cannabinoid CB1 receptor antagonist.
-
In Vitro——
-
In VivoAnimal Model:Male NMRI mice with the weight of 25-30 gDosage:0.62, 1.25 and 2.5 mg/kg (chronic administration); 2.5, 5 and 10 mg/kg (acute administration) Administration:Administrated i.p. every day concurrently with morphine except the day of experiment (chronic administration); Singly injected 40 min before second trial (acute administration)Result:The simultaneous daily administration of AM281 with morphine significantly shortened the exploration time, as compared with morphine-dependent mice receiving vehicle. Acute administration at a dose of 5 mg/kg, significantly augmented recognition index.
-
SynonymsAM281 | AM 281 | AM-281
-
PathwayMicrobiology/Virology
-
TargetHCV
-
RecptorCB
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number202463-68-1
-
Formula Weight557.21
-
Molecular FormulaC21H19Cl2IN4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 7.14 mg/mL (12.81 mM)
-
SMILESIc1ccc(c2n(nc(c2C)C(=O)NN2CCOCC2)c2c(Cl)cc(Cl)cc2)cc1
-
Chemical Name1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kadoi Y, et al. Crit Care Med. 2005 Nov;33(11):2629-36.
molnova catalog
related products
-
Combretastatin A4
Combretastatin A4 is a microtubule-targeting agent that binds β-tubulin (Kd: 0.4 μM).
-
Beclabuvir hydrochlo...
Beclabuvir (BMS-791325) is a potent allosteric inhibitor of HCV NS5B polymerase with EC50 of 6 and 3 nM for genotype 1b and 1a in FRET assays, respectively.
-
VCH-916 free acid(12...
VCH-916 is a novel nonnucleoside HCV NS5B polymerase inhibitor.
Cart
sales@molnova.com